VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Post by bullboardmonkeyon Mar 12, 2014 3:07pm

216 Views

Post# 22315226

The Stock Market Is A Perverted Beast

After years of research, development and clinical trials we finally aquire FDA Clearance for a device that could have a use in every hospital in the world, and the investment community at the moment could not care less.
Meanwhile, Abattis Bioceuticals, who have never grown a single marijuana plant and do not even have a license to grow yet, has now gone up 6100% since mid December.
This monkey is shaking his head.

Bullboard Posts

Three mispriced stocks exposed to major market tailwinds